Answer
With inotuzumab ozogamicin, women should use effective contraception during treatment and for at least 8 months after the final dose, and men with female partners of childbearing potential should do so during treatment and for at least 5 months after the final dose.
Sources for this answer
- BESPONSA 1 mg powder for concentrate for solution for infusionPfizer Limited · emc · SmPC §4.6 Fertility, pregnancy and lactation · Version 11Document updated
Sources checked